PT91031A - Processo para a preparacao de 13-alquil-11beta-fenil-gonanos e de composicoes farmaceuticas que os contem, assim como de produtos intermediarios necessarios para essa preparacao - Google Patents

Processo para a preparacao de 13-alquil-11beta-fenil-gonanos e de composicoes farmaceuticas que os contem, assim como de produtos intermediarios necessarios para essa preparacao

Info

Publication number
PT91031A
PT91031A PT91031A PT9103189A PT91031A PT 91031 A PT91031 A PT 91031A PT 91031 A PT91031 A PT 91031A PT 9103189 A PT9103189 A PT 9103189A PT 91031 A PT91031 A PT 91031A
Authority
PT
Portugal
Prior art keywords
alkyl
radicals
phonygonanes
benethenyl
preparing
Prior art date
Application number
PT91031A
Other languages
English (en)
Other versions
PT91031B (pt
Inventor
Gunfer Neef
Walter Elger
Sybille Beier
Eckhard Ottow
Stefan Scholz
Krzysztof Chwalisz
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of PT91031A publication Critical patent/PT91031A/pt
Publication of PT91031B publication Critical patent/PT91031B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Hydrogenated Pyridines (AREA)
  • Lubricants (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
PT91031A 1988-07-01 1989-06-30 Processo para a preparacao de 13-alquil-11beta-fenil-gonanos e de composicoes farmaceuticas que os contem, assim como de produtos intermediarios necessarios para essa preparacao PT91031B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3822770A DE3822770A1 (de) 1988-07-01 1988-07-01 13-alkyl-11ss-phenylgonane

Publications (2)

Publication Number Publication Date
PT91031A true PT91031A (pt) 1990-02-08
PT91031B PT91031B (pt) 1994-12-30

Family

ID=6358021

Family Applications (1)

Application Number Title Priority Date Filing Date
PT91031A PT91031B (pt) 1988-07-01 1989-06-30 Processo para a preparacao de 13-alquil-11beta-fenil-gonanos e de composicoes farmaceuticas que os contem, assim como de produtos intermediarios necessarios para essa preparacao

Country Status (17)

Country Link
US (2) US5273971A (pt)
EP (1) EP0349481B1 (pt)
JP (1) JP2956776B2 (pt)
AT (1) ATE129717T1 (pt)
AU (1) AU644060B2 (pt)
CA (1) CA1334668C (pt)
DD (2) DD287511A5 (pt)
DE (2) DE3822770A1 (pt)
ES (1) ES2080079T3 (pt)
GR (1) GR3018069T3 (pt)
HU (1) HU208021B (pt)
IE (1) IE70664B1 (pt)
IL (1) IL90826A (pt)
NO (1) NO180451C (pt)
PT (1) PT91031B (pt)
WO (1) WO1990000174A1 (pt)
ZA (1) ZA895058B (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3822770A1 (de) * 1988-07-01 1990-01-04 Schering Ag 13-alkyl-11ss-phenylgonane
US5707982A (en) * 1989-02-24 1998-01-13 Roussel Uclaf 19-nor-steroids
US6790971B1 (en) * 1989-02-24 2004-09-14 Aventis Pharma S.A. 19-Nor-steroids
DE4018168A1 (de) * 1990-06-01 1991-12-05 Schering Ag Ausgangsverbindungen fuer die herstellung von 10ss-h-steroiden und ein verfahren zur herstellung dieser ausgangsverbindungen
DE4042004A1 (de) * 1990-12-22 1992-06-25 Schering Ag 14(beta)-h-, 14- u. 15-en-11(beta)-aryl-4-estrene
EP0683172B1 (en) * 1994-05-19 1997-08-13 Akzo Nobel N.V. 11,21-Bisphenyl-19-norpregnane derivatives
DE4434488A1 (de) * 1994-09-14 1996-03-21 Schering Ag Steroidester und -amide, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
US5929262A (en) * 1995-03-30 1999-07-27 The United States Of America As Represented By The Department Of Health And Human Services Method for preparing 17α-acetoxy-11β-(4-N, N-dimethylaminophyl)-19-Norpregna-4,9-diene-3, 20-dione, intermediates useful in the method, and methods for the preparation of such intermediates
CA2253673C (en) * 1996-05-01 2009-09-08 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services 21-substituted progesterone derivatives as new antiprogestational agents
US6900193B1 (en) * 1996-05-01 2005-05-31 The United States Of America As Represented By The Department Of Health And Human Services Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents
US6020328A (en) * 1998-03-06 2000-02-01 Research Triangle Institute 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US6262042B1 (en) 1998-05-29 2001-07-17 Research Triangle Institute 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US5962444A (en) * 1998-05-29 1999-10-05 Research Triangle Institute 17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
SK882003A3 (en) * 2000-07-28 2003-07-01 Akzo Nobel Nv 16alpha-substituted steroid compounds, pharmaceutical composition comprising same and their use
EP1613640A4 (en) * 2003-02-28 2010-05-19 Us Gov Health & Human Serv PROCESS FOR PREPARING 17 ALPHA-ACETOXY-11 BETA- (4-N, N-DIMETHYLAMINOPHENYL) -19-NORPREGNA-4,9-DIENE-3,20-DION, INTERMEDIATE PRODUCTS AND METHOD OF MANUFACTURING THESE INTERMEDIATE PRODUCTS
TW200531977A (en) * 2004-03-25 2005-10-01 Akzo Nobel Nv Progesterone receptor modulators
US20060196449A1 (en) * 2004-09-17 2006-09-07 Mockry Eldon F Fluid heating system and method
US9517240B2 (en) 2006-09-26 2016-12-13 The Regents Of The University Of California Methods and compositions for cancer prevention and treatment
WO2008039482A2 (en) * 2006-09-26 2008-04-03 The Regents Of The University Of California Methods and compositions for cancer prevention and treatment
EP3693376A1 (en) 2006-10-24 2020-08-12 Allergan Pharmaceuticals International Limited Compositions for suppressing endometrial proliferation
US7784843B2 (en) * 2008-01-08 2010-08-31 Toyota Motor Engineering & Manufacturing North America, Inc. Vehicle console with sliding panel
US8172293B2 (en) * 2008-01-09 2012-05-08 Toyota Motor Engineering & Manufacturing North America, Inc. Vehicle electronic device support systems
TWI539953B (zh) 2008-04-28 2016-07-01 瑞波若斯治療學公司 用於治療乳癌之組成物和方法
EP2550288A1 (en) 2010-03-22 2013-01-30 Repros Therapeutics Inc. Compositions and methods for non-toxic delivery of antiprogestins
CN105142644A (zh) 2013-03-12 2015-12-09 阿尔诺治疗公司 奥那司酮多晶型形式和使用方法
US9096641B2 (en) * 2013-06-05 2015-08-04 Evestra, Inc. Imidazolyl progesterone antagonists
US10786461B2 (en) 2014-11-17 2020-09-29 Context Biopharma Inc. Onapristone extended-release compositions and methods
BR112018005999A2 (pt) 2015-09-25 2019-01-08 Context Biopharma Inc métodos para a produção de intermediários de onapristona
KR20180113988A (ko) 2015-12-15 2018-10-17 컨텍스트 바이오파마 인코포레이티드 비정질 오나프리스톤 조성물 및 그 제조방법
US20180148471A1 (en) 2016-11-30 2018-05-31 Arno Therapeutics, Inc. Methods for onapristone synthesis dehydration and deprotection

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3971772A (en) * 1975-01-06 1976-07-27 E. R. Squibb & Sons, Inc. Steroidal[16α,17-b]1,4-dioxanes and Steroidal[16α,17-b]1,4-dioxins
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
FR2522328B1 (fr) * 1982-03-01 1986-02-14 Roussel Uclaf Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments
ES533260A0 (es) * 1983-06-15 1985-02-01 Schering Ag Procedimiento para la preparacion de 13a-alquilgonanos
US4780461A (en) * 1983-06-15 1988-10-25 Schering Aktiengesellschaft 13α-alkyl-gonanes, their production, and pharmaceutical preparations containing same
FR2576025B1 (fr) * 1985-01-14 1987-01-23 Roussel Uclaf Nouveaux steroides substitues en position 10, leur procede et les intermediaires de preparation, leur application comme medicaments, les compositions pharmaceutiques les contenant
AU580843B2 (en) * 1985-02-07 1989-02-02 Schering Aktiengesellschaft 11``-phenyl-gonanes, their manufacture and pharmaceutical preparations containing them
DE3625315A1 (de) * 1986-07-25 1988-01-28 Schering Ag 11ss-(4-isopropenylphenyl)-estra-4,9-diene, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3822770A1 (de) * 1988-07-01 1990-01-04 Schering Ag 13-alkyl-11ss-phenylgonane
DE3832303A1 (de) * 1988-09-20 1990-04-12 Schering Ag 11ss-phenyl-14ssh-steroide

Also Published As

Publication number Publication date
IL90826A0 (en) 1990-01-18
JP2956776B2 (ja) 1999-10-04
ATE129717T1 (de) 1995-11-15
NO905609D0 (no) 1990-12-27
EP0349481A1 (de) 1990-01-03
NO180451B (no) 1997-01-13
DD295638A5 (de) 1991-11-07
IE892141L (en) 1990-01-01
DD287511A5 (de) 1991-02-28
US5446036A (en) 1995-08-29
CA1334668C (en) 1995-03-07
WO1990000174A1 (de) 1990-01-11
AU644060B2 (en) 1993-12-02
JPH03505727A (ja) 1991-12-12
NO180451C (no) 1997-04-23
DE3822770A1 (de) 1990-01-04
PT91031B (pt) 1994-12-30
EP0349481B1 (de) 1995-11-02
HUT56114A (en) 1991-07-29
NO905609L (no) 1991-02-28
IL90826A (en) 1994-06-24
HU208021B (en) 1993-07-28
DE58909476D1 (de) 1995-12-14
US5273971A (en) 1993-12-28
ZA895058B (en) 1990-04-25
ES2080079T3 (es) 1996-02-01
AU3856889A (en) 1990-01-23
HU894130D0 (en) 1991-06-28
GR3018069T3 (en) 1996-02-29
IE70664B1 (en) 1996-12-11

Similar Documents

Publication Publication Date Title
PT91031A (pt) Processo para a preparacao de 13-alquil-11beta-fenil-gonanos e de composicoes farmaceuticas que os contem, assim como de produtos intermediarios necessarios para essa preparacao
KR950700296A (ko) 비닐렌-아자인돌 유도체 및 이의 제조방법(Vinylene-Azaindole derivatives and process for their preparation)
ES8300716A1 (es) Procedimiento para preparar derivados de 2-amino-4-hidroxi- quinazolina
FI921030A (fi) Cykliska ureaderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning
BR8801410A (pt) Composicao fotoendurecivel
DK0673372T3 (da) Nye taxoider, deres fremstilling og farmaceutiske præparater indeholdende disse taxoider
ES2066875T3 (es) Aminoalquilindoles, procedimiento para su obtencion y preparados farmaceuticos que los contienen.
KR880003622A (ko) 카테콜유도체 및 그것을 함유하는 중추신경계 퇴행성 질환의 진행방지 및 치료제
AU660469B2 (en) Pharmacologically active hydrazine derivatives and processes for the preparation thereof
PT81855B (pt) Processo de preparacao de arilciclobutilalquilaminas e de composicoes farmaceuticas que as contem
DK0558416T3 (da) 17-methylenlactonsteroider, deres fremstilling, mellemprodukter dertil, deres anvendelse som lægemidler samt farmaceutiske præparater med indhold deraf
DK1020474T3 (da) Oligosaccharidderivater og fremgangsmåde til fremstilling af samme
SE8403268L (sv) 1,4-dihydropyridinderivat, deras framstellning och farmaceutiska beredningar innehallande dessa
JPS6431752A (en) Amide derivative and skin external preparation containing said derivative
ATE102924T1 (de) 1-(4-aminophenyl)-2-piperidinopropanon-derivate verfahren zu deren herstellung und therapeutische verwendung.
KR870004038A (ko) 제초제 화합물의 제조방법
MX9303753A (es) Dihidropiridinas anilladas y composiciones farmaceuticas que las contienen.
DE3866603D1 (de) 1-benzoyl-2-oxo-5-alkoxy-pyrrolidin-derivate, ihre herstellung und verwendung als heilmittel und zubereitungen, die sie enthalten.
ES2007666A6 (es) Procedimiento para preparar derivados de isoquinolina y composiciones farmaceuticas correspondientes.
PT90509A (pt) Processo para a preparacao de derivados de cefalosporina e de composicoes farmaceuticas que os contem
DK99588A (da) 2-(aminoalkythio)methyl-1,4-dihydropyridin-forbindelser, en fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem
KR890001932A (ko) 브라시노라이드 유사체

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19940620

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19991231